Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction: Results from the Norwegian heart failure registry

Journal of the American College of Cardiology

Volumn 59, Issue 4, 2012, Pages 371-378

  Waldum, Brd ^a,b   Westheim, Arne S ^b   Sandvik, Leiv ^b   Flønæs, Berit ^c   Grundtvig, Morten ^d   Gullestad, Lars ^e   Hole, Torstein ^f,g   Os, Ingrid ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c VESTRE VIKEN HOSPITAL TRUST   (Norway)

^d INNLANDET HOSPITAL TRUST   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^g Sunnmøre Hospital Trust   (Norway)

Author keywords

anemia; heart failure; mortality; renal dysfunction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; FUROSEMIDE; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE; WARFARIN;

AGE; AGED; ANEMIA; ARTICLE; BODY MASS; CLINICAL CLASSIFICATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS; NORWAY; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; ANEMIA; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NORWAY; REGISTRIES;

EID: 84855969520     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.10.864     Document Type: Article

References (20)

1. I.S. Anand Anemia and chronic heart failure implications and treatment options J Am Coll Cardiol 52 2008 501 511
2. G. Weiss, L.T. Goodnough Anemia of chronic disease N Engl J Med 352 2005 1011 1023
3. P. van der Meer, E. Lipsic, B.D. Westenbrink Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure Circulation 112 2005 1743 1747 (Pubitemid 41368150)
4. J. Lindenfeld Prevalence of anemia and effects on mortality in patients with heart failure Am Heart J 149 2005 391 401 (Pubitemid 40585400)
5. H.F. Groenveld, J.L. Januzzi, K. Damman Anemia and mortality in heart failure patients a systematic review and meta-analysis J Am Coll Cardiol 52 2008 818 827
6. A.C. Salisbury, M. Kosiborod Outcomes associated with anemia in patients with heart failure Heart Fail Clin 6 2010 359 372
7. M. Grundtvig, L. Gullestad, T. Hole, B. Flonaes, A. Westheim Characteristics, implementation of evidence-based management and outcome in patients with chronic heart failure: results from the Norwegian heart failure registry Eur J Cardiovasc Nurs 10 2011 44 49
8. W.J. Remme, K. Swedberg Guidelines for the diagnosis and treatment of chronic heart failure Eur Heart J 22 2001 1527 1560 (Pubitemid 32801300)
9. World Health Organization Iron Deficiency Anaemia Assessment, Prevention and Control: A Guide for Programme Managers 2001 World Health Organization Geneva, Switzerland
10. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification Am J Kidney Dis 39 Suppl 1 2002 s1 s246
11. M.H. Katz Assumptions of multiple linear regression, multiple logistic regression, and proportional hazards analysis M.H. Katz, Multivariable Analysis 2006 Cambridge University Press Cambridge 38 67
12. B. Waldum, A.S. Westheim, L. Sandvik Renal function in outpatients with chronic heart failure J Card Fail 16 2010 374 380
13. A. Kazory, E.A. Ross Anemia: the point of convergence or divergence for kidney disease and heart failure? J Am Coll Cardiol 53 2009 639 647
14. A.S. Go, J. Yang, L.M. Ackerson Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) study Circulation 113 2006 2713 2723 (Pubitemid 43947989)
15. S.D. Anker, C.J. Comin, G. Filippatos Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 2009 2436 2448
16. W.T. Abraham, I.S. Anand, M. Klapholz Treatment of anemia with darbepoetin alfa in heart failure Congest Heart Fail 16 2010 87 95
17. P. Ponikowski, S.D. Anker, J. Szachniewicz Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial J Am Coll Cardiol 49 2007 753 762 (Pubitemid 46240705)
18. J.R. Wu, D.K. Moser, M.L. Chung, T.A. Lennie Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure J Card Fail 14 2008 203 210 (Pubitemid 351434593)
19. W.H. Tang, W. Tong, A. Jain, G.S. Francis, C.M. Harris, J.B. Young Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure J Am Coll Cardiol 51 2008 569 576
20. M. Komajda, S.D. Anker, A. Charlesworth The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET Eur Heart J 27 2006 1440 1446 (Pubitemid 43998078)